Autologous haematopoietic stem cell transplantation compared with alemtuzumab for relapsing-remitting multiple sclerosis: an observational study.
J Neurol Neurosurg Psychiatry
; 92(2): 189-194, 2021 02.
Article
in En
| MEDLINE
| ID: mdl-33106366
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Neuroprotective Agents
/
Hematopoietic Stem Cell Transplantation
/
Multiple Sclerosis, Relapsing-Remitting
/
Alemtuzumab
Type of study:
Observational_studies
/
Risk_factors_studies
Limits:
Adult
/
Female
/
Humans
/
Male
Language:
En
Journal:
J Neurol Neurosurg Psychiatry
Year:
2021
Document type:
Article
Affiliation country:
Suecia